Toxicology – Tachycardia

Definition

Tachycardia is an abnormally elevated heart rate relative to age and physiologic state.

In adults, resting heart rate >100 beats/min is generally considered tachycardia.

In children, normal heart rate varies substantially with age, activity, fever, distress, and clinical condition. Therefore, pediatric tachycardia should be interpreted using age-appropriate reference ranges rather than a single rigid cutoff.

Tachycardia is a clinical sign rather than a diagnosis. In toxicology, identifying the mechanism and underlying poison is more important than simply reducing the heart rate.

Pathophysiology

Toxicant-associated tachycardia can develop through several mechanisms:

• Excess sympathetic stimulation
• β-adrenergic receptor stimulation
• Muscarinic receptor blockade
• Peripheral vasodilation with reflex tachycardia
• Myocardial irritability
• Drug-induced dysrhythmia
• Hyperthermia
• Hypoxia
• Hypotension
• Hypovolemia
• Metabolic acidosis
• Withdrawal syndromes

A rapid heart rate may therefore represent an appropriate compensatory response rather than primary cardiac toxicity.

Major Toxicologic Mechanisms

Sympathomimetic Stimulation

Sympathomimetics increase catecholaminergic activity.

Important causes include:

• Cocaine
• Amphetamines
• Methamphetamine
• Ephedrine
• Other stimulants
• β₂-adrenergic agonists

Typical findings include:

• Tachycardia
• Hypertension
• Mydriasis
• Diaphoresis
• Agitation
• Tremor
• Hyperthermia

Severe toxicity can produce:

• Seizures
• Rhabdomyolysis
• Dysrhythmias
• Myocardial ischemia
• Metabolic acidosis

Anticholinergic Toxicity

Antimuscarinic drugs commonly produce sinus tachycardia.

Potential causes include:

• Diphenhydramine
• Other first-generation antihistamines
• Atropine
• Scopolamine
• Antipsychotics with antimuscarinic activity
• Jimsonweed and related plants

Clinical findings include:

• Tachycardia
• Mydriasis
• Dry mucous membranes
• Dry, flushed skin
• Hyperthermia
• Urinary retention
• Reduced bowel sounds
• Agitation
• Hallucinations
• Delirium

A useful distinction from sympathomimetic toxicity is:

Anticholinergic → hot and dry

Sympathomimetic → hot and sweaty

Tricyclic Antidepressants

TCA poisoning commonly causes tachycardia through:

• Antimuscarinic activity
• Norepinephrine reuptake inhibition
• Cardiovascular toxicity

More concerning findings include:

• Altered mental status
• Seizures
• Hypotension
• QRS widening
• Ventricular dysrhythmias

Tachycardia accompanied by QRS widening and hypotension should raise concern for significant sodium-channel blockade.

Sodium bicarbonate is the major treatment for clinically important TCA-related sodium-channel cardiotoxicity.

Other Sodium-Channel-Blocking Drugs

Several drugs can produce:

Tachycardia + QRS widening + hypotension ± ventricular dysrhythmias

Examples include:

• TCAs
• Certain first-generation antihistamines
• Class IA antiarrhythmics
• Some other membrane-stabilizing drugs

ECG evaluation is therefore essential in toxicologic tachycardia.

Theophylline

Theophylline toxicity commonly produces marked tachycardia.

Associated findings include:

• Nausea and vomiting
• Tremor
• Agitation
• Hypokalemia
• Hyperglycemia
• Seizures
• Supraventricular or ventricular dysrhythmias

Severe theophylline poisoning can deteriorate rapidly.

β₂-Adrenergic Agonists

Excessive β₂-agonist exposure can produce:

• Tachycardia
• Tremor
• Hypokalemia
• Hyperglycemia
• Lactic acidosis

The heart-rate elevation may result from both direct β-receptor effects and physiologic responses to metabolic changes.

Digoxin

Digoxin toxicity does not have one characteristic heart rate.

It can cause numerous rhythm disturbances, including combinations of:

• Bradycardia
• AV block
• Atrial tachyarrhythmias
• Ventricular ectopy
• Ventricular tachycardia

Associated findings may include:

• Nausea/vomiting
• Confusion
• Visual disturbances
• Hyperkalemia in significant acute poisoning

The combination of a tachyarrhythmia with AV conduction abnormalities can suggest digoxin toxicity.

Monoamine Oxidase Inhibitors

MAOI toxicity may produce:

• Tachycardia
• Hypertension
• Hyperthermia
• Agitation
• Altered mental status
• Neuromuscular abnormalities

Severe poisoning can progress to:

• Seizures
• Rigidity
• Cardiovascular instability
• Coma

Serotonergic Drugs

Serotonergic toxicity may cause tachycardia as part of autonomic hyperactivity.

Serotonin syndrome typically includes:

• Agitation
• Diaphoresis
• Tachycardia
• Hyperthermia
• Hyperreflexia
• Tremor
• Clonus

Clonus and hyperreflexia are particularly useful diagnostic findings.

Isolated SSRI overdose is often less severe than serotonin syndrome caused by significant serotonergic interactions or more toxic serotonergic agents.

Carbamazepine

Carbamazepine toxicity may produce:

• Tachycardia
• Nystagmus
• Ataxia
• CNS depression
• Coma
• Seizures

Severe poisoning can also produce cardiac conduction abnormalities.

Cholinergic Poisoning

Organophosphate and carbamate poisoning are commonly associated with bradycardia, but tachycardia can also occur.

Clinical findings include:

• Miosis
• Salivation
• Lacrimation
• Sweating
• Bronchorrhea
• Vomiting
• Diarrhea
• Fasciculations
• Weakness

Heart rate alone should therefore not be used to exclude a cholinergic syndrome.

Methemoglobinemia

Methemoglobinemia reduces effective oxygen delivery.

Compensatory findings may include:

• Tachycardia
• Tachypnea
• Cyanosis
• Headache
• Dizziness
• Dyspnea

A characteristic clue is cyanosis with an oxygen saturation that does not improve as expected with supplemental oxygen.

Diagnosis is confirmed using co-oximetry.

Thyroid Hormone Toxicity

Excess thyroid hormone can cause:

• Persistent tachycardia
• Tremor
• Anxiety
• Diaphoresis
• Hyperthermia
• Hypertension

Severe thyrotoxicosis may produce:

• Atrial fibrillation
• Heart failure
• Delirium
• Cardiovascular instability

Symptoms after an acute thyroid hormone ingestion may be delayed because hormonal effects develop over time.

Vasodilators

Vasodilator medications may produce reflex tachycardia secondary to reduced systemic vascular resistance.

Examples include:

• Dihydropyridine calcium channel blockers
• Hydralazine
• Nitrates

The key mechanism is:

Vasodilation → decreased blood pressure → baroreceptor activation → sympathetic response → tachycardia

Withdrawal Syndromes

Withdrawal from certain substances may produce autonomic hyperactivity.

Important causes include:

• Alcohol
• Benzodiazepines
• Barbiturates
• Opioids

Possible findings include:

• Tachycardia
• Hypertension
• Diaphoresis
• Tremor
• Anxiety
• Agitation

Alcohol or sedative-hypnotic withdrawal may additionally cause:

• Hallucinations
• Hyperthermia
• Seizures

Nontoxicologic Causes

Not every tachycardia in a poisoned patient is directly caused by the toxicant.

Important alternative causes include:

• Pain
• Anxiety
• Fever
• Dehydration
• Hemorrhage
• Anemia
• Hypoxia
• Pulmonary embolism
• Sepsis
• Metabolic acidosis
• Hyperthyroidism
• Cardiac dysrhythmia

Persistent unexplained tachycardia should prompt investigation for these conditions.

Clinical Assessment

The first important question is whether the rhythm represents:

Sinus tachycardia or a primary tachydysrhythmia?

Sinus tachycardia is usually a physiologic response to an underlying problem.

A primary tachydysrhythmia may require rhythm-specific management.

Vital-Sign Patterns

Tachycardia + Hypertension

Consider:

• Sympathomimetics
• Anticholinergic poisoning
• MAOI toxicity
• Serotonin syndrome
• Alcohol or sedative withdrawal
• Hyperthermia

Tachycardia + Hypotension

Consider:

• TCA poisoning
• Theophylline toxicity
• Severe vasodilator poisoning
• Chloroquine/hydroxychloroquine toxicity
• Shock
• Volume depletion

This combination is particularly concerning for cardiovascular toxicity or hemodynamic compromise.

Tachycardia + Hyperthermia

Consider:

• Sympathomimetic toxicity
• Anticholinergic toxicity
• Serotonin syndrome
• MAOI toxicity
• Severe withdrawal
• Thyrotoxicosis

Hyperthermia substantially increases the risk of:

• Rhabdomyolysis
• Metabolic acidosis
• Acute kidney injury
• Dysrhythmias
• Multiorgan failure

Pupil and Skin Findings

Mydriasis + Diaphoresis

Suggests:

Sympathomimetic syndrome

Mydriasis + Dry Skin

Suggests:

Anticholinergic syndrome

Miosis + Secretions

Suggests:

Cholinergic syndrome

Cyanosis

Consider:

• Severe hypoxemia
• Methemoglobinemia

Gastrointestinal Findings

Vomiting

May occur with:

• Theophylline
• Salicylates
• Iron
• Digoxin
• Cholinergic poisoning

Reduced Bowel Sounds

Supports an anticholinergic syndrome.

Diarrhea + Excessive Secretions

Supports a cholinergic syndrome.

Neurologic Findings

Agitation and Delirium

Consider:

• Stimulants
• Anticholinergic agents
• Hallucinogens
• Withdrawal

Tremor

Consider:

• Theophylline
• β₂-agonists
• Stimulants
• Thyroid hormone
• Withdrawal

Seizures

Tachycardia accompanied by seizures should raise concern for:

• TCAs
• Bupropion
• Theophylline
• Stimulants
• Antihistamines
• MAOIs
• Severe withdrawal

ECG Evaluation

An ECG should be obtained in persistent or clinically significant toxicologic tachycardia.

Assess:

• Rhythm
• Heart rate
• PR interval
• QRS duration
• QT/QTc
• AV conduction
• Ventricular ectopy
• Ischemic abnormalities

Continuous cardiac monitoring is appropriate when significant poisoning or dysrhythmia is suspected.

QRS Widening

Tachycardia with QRS widening should raise concern for sodium-channel blockade.

Important causes include:

• TCAs
• Class IA antiarrhythmics
• Certain antihistamines
• Other sodium-channel-blocking medications

A prominent terminal R wave in lead aVR can support sodium-channel blockade, but it is not specific enough to diagnose TCA poisoning by itself.

QT Prolongation

Certain toxicants can prolong ventricular repolarization and increase the risk of torsades de pointes.

Potential causes include:

• Some antiarrhythmics
• Antipsychotics
• Certain antidepressants
• Methadone
• Other QT-prolonging medications

Evaluate and correct contributing abnormalities such as:

• Hypokalemia
• Hypomagnesemia
• Bradycardia when clinically relevant

Laboratory Evaluation

Testing should be guided by the clinical presentation.

Possible studies include:

• Bedside glucose
• CBC
• Electrolytes
• Bicarbonate
• Potassium
• Magnesium
• Renal function
• Blood gas
• Lactate
• CK when rhabdomyolysis is suspected

Targeted toxicologic tests may include:

• Salicylate concentration
• Acetaminophen concentration when overdose is possible
• Digoxin concentration
• Theophylline concentration
• Other drug-specific concentrations

Broad urine toxicology screening has limited sensitivity and specificity and should not replace clinical assessment.

Tachycardia With Metabolic Acidosis

Unexplained tachycardia accompanied by metabolic acidosis requires careful investigation.

Potential causes include:

• Salicylates
• Toxic alcohols
• Carbon monoxide
• Cyanide
• Severe stimulant toxicity
• Seizures
• Shock
• Sepsis
• Diabetic ketoacidosis

The anion gap, lactate, blood gas, exposure history, and targeted toxicology testing can help determine the cause.

Management Principles

The major principle is:

Treat the cause of the tachycardia rather than the heart rate alone.

Examples:

• Hypoxia → improve oxygenation/ventilation
• Hypovolemia → appropriate fluid replacement
• Hyperthermia → rapid cooling
• Hypoglycemia → correct glucose
• Electrolyte abnormality → correct the disturbance
• Agitation → appropriate sedation
• Sodium-channel blockade → sodium bicarbonate
• Withdrawal → syndrome-specific treatment

Agitation-Related Tachycardia

Agitation itself can substantially increase sympathetic activity.

When agitation results from stimulant toxicity or withdrawal, benzodiazepines are often first-line therapy.

Appropriate sedation can improve:

• Tachycardia
• Hypertension
• Agitation
• Muscle activity
• Hyperthermia risk

Airway and respiratory status should be monitored during sedative treatment.

Beta-Blockers

Beta-blockade should not be used routinely simply to normalize toxicologic sinus tachycardia.

The appropriateness of a beta-blocker depends on:

• Toxicant involved
• Blood pressure
• Rhythm
• Presence of myocardial ischemia
• Degree of sympathetic stimulation

In stimulant-associated cardiovascular toxicity, treatment generally emphasizes sedation and appropriate vasodilator therapy when needed, rather than reflexively treating the heart rate with isolated beta-blockade.

Hypotension

When tachycardia accompanies hypotension, determine whether the cause is:

• Hypovolemia
• Vasodilation
• Myocardial depression
• Dysrhythmia
• Severe metabolic toxicity

Fluids should be administered according to the patient’s volume status and response.

Persistent shock may require:

• Vasopressors
• Toxin-specific cardiovascular therapy
• Advanced circulatory support in selected severe poisonings

Routine large-volume fluid administration should be avoided when cardiogenic toxicity is possible.

Hypertension

When tachycardia and hypertension result from severe sympathetic activation:

Control agitation and sympathetic excess first.

Benzodiazepines are particularly useful for stimulant-related agitation.

Persistent severe hypertension or acute target-organ injury may require a short-acting, titratable antihypertensive agent selected according to the toxicant and clinical situation.

Decontamination

Induced vomiting is not recommended.

Routine gastric lavage is generally not indicated.

Activated charcoal may be considered for selected recent, serious, adsorbable ingestions when:

• The expected benefit is meaningful.
• Aspiration risk is acceptable.
• The airway is adequately protected.

Decontamination should never delay cardiovascular stabilization.

Monitoring

Patients with significant toxicologic tachycardia should be monitored for:

• Heart rate and rhythm
• Blood pressure
• Mental status
• Temperature
• Oxygenation
• QRS and QT abnormalities
• Electrolyte disturbances

Additional monitoring depends on the suspected poison.

Disposition

Disposition depends primarily on the underlying toxicant and associated abnormalities, rather than the heart rate alone.

Hospital observation or admission may be necessary when there is:

• Persistent unexplained tachycardia
• QRS or QT abnormalities
• Hypotension
• Severe hypertension
• Hyperthermia
• Seizures
• Altered mental status
• Significant metabolic abnormalities
• Potential delayed toxicity

Key Points

• Tachycardia is a clinical sign, not a specific diagnosis.
• In adults, resting heart rate >100 beats/min generally meets the definition of tachycardia; pediatric interpretation is age-dependent.
• Common toxicologic mechanisms include sympathetic stimulation, anticholinergic activity, reflex tachycardia, hyperthermia, hypoxia, hypotension, and volume depletion.
• Sympathomimetic toxicity causes tachycardia with diaphoresis, whereas anticholinergic toxicity typically causes tachycardia with dry skin and mucous membranes.
• Important toxicologic causes include stimulants, TCAs, antihistamines, theophylline, β₂-agonists, MAOIs, serotonergic drugs, thyroid hormone, and withdrawal syndromes.
• Tachycardia with QRS widening should raise concern for sodium-channel-blocking toxicity.
• A terminal R wave in aVR may support sodium-channel blockade but is not specific for TCA poisoning.
• Theophylline and β₂-agonist toxicity may produce hypokalemia.
• Tachycardia with cyanosis should raise concern for hypoxemia or methemoglobinemia.
• Obtain an ECG in clinically significant or unexplained toxicologic tachycardia.
• Management should focus on the underlying cause rather than simply lowering the heart rate.
• Benzodiazepines are often useful when tachycardia is driven by stimulant-induced agitation or withdrawal.
• Beta-blockers should not be used reflexively for toxicologic sinus tachycardia.
• Persistent tachycardia accompanied by hypotension, hyperthermia, altered mental status, seizures, QRS widening, or metabolic acidosis suggests potentially severe poisoning.